TR | EN

Anasayfa : Ülkemizde Yürüyen Çalışmalar : Uluslararası Çalışmalar

Uluslararası Çalışmalar

Study List


Study 3:
Title: A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Multiple Myeloma
Interventions:
URL: https://ClinicalTrials.gov/show/NCT02387879
Study 4:
Title: A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Follicular Lymphoma
Interventions: Biological: PF-05280586|Biological: MabThera®
URL: https://ClinicalTrials.gov/show/NCT02213263
Study 16:
Title: RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Venous Thromboembolism
Interventions:
URL: https://ClinicalTrials.gov/show/NCT02596230
Study 22:
Title: Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Lymphoma, Large B-Cell, Diffuse
Interventions: Drug: lenalidomide|Drug: Placebo|Drug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: prednisone|Drug: vincristine
URL: https://ClinicalTrials.gov/show/NCT02285062
Study 23:
Title: A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Heart Failure|Respiratory Insufficiency|Stroke Acute|Infectious Diseases|Rheumatic Diseases
Interventions: Drug: Rivaroxaban, 10 mg|Drug: Rivaroxaban, 7.5 mg|Drug: Placebo
URL: https://ClinicalTrials.gov/show/NCT02111564
Study 25:
Title: A Safety Study of Obinutuzumab Alone or in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Chronic Lymphocytic Leukemia
Interventions: Drug: chemotherapy|Drug: obinutuzumab
URL: https://ClinicalTrials.gov/show/NCT01905943
Study 35:
Title: Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Multiple Myeloma
Interventions: Drug: Pomalidomide|Drug: Bortezomib|Drug: Dexamethasone
URL: https://ClinicalTrials.gov/show/NCT01734928
Study 59:
Title: A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Multiple Myeloma
Interventions: Drug: Velcade|Drug: Melphalan|Drug: Prednisone|Drug: Daratumumab
URL: https://ClinicalTrials.gov/show/NCT02195479
Study 60:
Title: Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Lymphoma, Non-Hodgkin
Interventions: Drug: Rituximab|Drug: Lenalidomide|Drug: Rituximab|Drug: Placebo
URL: https://ClinicalTrials.gov/show/NCT01938001
Study 61:
Title: A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Lymphoma
Interventions: Drug: Ibrutinib|Drug: Placebo|Drug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone (or equivalent)
URL: https://ClinicalTrials.gov/show/NCT01855750
Study 65:
Title: Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Hemophilia A
Interventions: Biological: Moroctocog alfa (AF-CC)|Biological: Moroctocog alfa (AF-CC)
URL: https://ClinicalTrials.gov/show/NCT00543439
Study 75:
Title: The International ITP Registry
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Thrombocytopenia
Interventions:
URL: https://ClinicalTrials.gov/show/NCT01970189
Study 88:
Title: Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Lymphoma,Non-Hodgkin
Interventions: Drug: Copanlisib (BAY 80-6946)|Drug: Placebo|Drug: Rituximab
URL: https://ClinicalTrials.gov/show/NCT02367040
Study 94:
Title: Safety of Dabigatran Etexilate in Blood Clot Prevention in Children
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Venous Thromboembolism|Secondary Prevention
Interventions: Drug: dabigatran etexilate
URL: https://ClinicalTrials.gov/show/NCT02197416
Study 101:
Title: Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Venous Thromboembolism
Interventions: Drug: dabigatran etexilate|Drug: standard of care
URL: https://ClinicalTrials.gov/show/NCT01895777
Study 124:
Title: A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Patients With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Diffuse Large B-Cell Lymphoma, Lymphoma, Non Hodgkin, Lymphoma, Follicular
Interventions: Drug: bendamustine|Drug: obinutuzumab|Drug: polatuzumab vedotin|Drug: rituximab
URL: https://ClinicalTrials.gov/show/NCT02257567
Study 139:
Title: Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Lymphoma, Non-Hodgkin
Interventions: Drug: Copanlisib (BAY80-6946)
URL: https://ClinicalTrials.gov/show/NCT01660451
Study 140:
Title: Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Severe Sepsis|Coagulopathy
Interventions: Drug: ART-123|Drug: Placebo
URL: https://ClinicalTrials.gov/show/NCT01598831
Study 141:
Title: Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Cancer|Hematologic Malignancies|Multiple Myeloma|Oncology|Bone Metastases|Multiple Myeloma Bone Lesions
Interventions: Drug: Denosumab|Drug: Zoledronic acid
URL: https://ClinicalTrials.gov/show/NCT01345019
Study 148:
Title: An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Lymphoma, Mantle-Cell|Lymphoma, Large B-Cell, Diffuse|Lymphoma, Follicular
Interventions: Drug: Daratumumab
URL: https://ClinicalTrials.gov/show/NCT02413489
Study 150:
Title: Pharmacokinetic and Pharmacodynamic Study to Evaluate Safety and Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Hematologic Neoplasms
Interventions: Drug: Ibrutinib|Drug: Nivolumab
URL: https://ClinicalTrials.gov/show/NCT02329847
Study 152:
Title: A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Smoldering Multiple Myeloma (SMM)
Interventions: Drug: daratumumab|Drug: daratumumab|Drug: daratumumab
URL: https://ClinicalTrials.gov/show/NCT02316106
Study 155:
Title: Single Arm, Open-label, Long-term Study of Romiplostim in Thrombocytopenic Pediatric Subjects With ITP.
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Immune Thrombocytopenia (ITP)
Interventions: Drug: Romiplostim
URL: https://ClinicalTrials.gov/show/NCT02279173
Study 156:
Title: A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Thrombocytopaenia
Interventions: Drug: Eltrombopag|Drug: Azacitidine|Drug: Placebo
URL: https://ClinicalTrials.gov/show/NCT02158936
Study 162:
Title: Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Leukemia, Myeloid, Acute
Interventions: Drug: 300 mg Oral Azacitidine|Drug: Placebo
URL: https://ClinicalTrials.gov/show/NCT01757535
Study 170:
Title: A Study to Evaluate the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Sickle Cell Disease
Interventions: Drug: Ticagrelor|Drug: Placebo|Drug: Analgesic
URL: https://ClinicalTrials.gov/show/NCT02482298
Study 171:
Title: An Open-Label, Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Subjects With Stage IV Non-Small Cell Lung Cancer (NSCLC)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Non-Small Cell Lung Cancer
Interventions: Drug: Nivolumab|Drug: Ipilimumab|Drug: Carboplatin|Drug: Cisplatin|Drug: Gemcitabine|Drug: Pemetrexed
URL: https://ClinicalTrials.gov/show/NCT02477826
Study 184:
Title: An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Hemophilia A|Severe Hemophilia A
Interventions: Biological: rVIII-SingleChain
URL: https://ClinicalTrials.gov/show/NCT02172950
Study 196:
Title: Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Vaso-occlusive Crisis|Sickle Cell Disease
Interventions: Drug: Saline|Drug: MST-188
URL: https://ClinicalTrials.gov/show/NCT01737814
Study 216:
Title: Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Pulmonary Embolism|Thromboembolism|Thrombosis|Venous Thrombosis|Venous Thromboembolism
Interventions: Drug: BAY 59-7939|Drug: BAY 59-7939|Drug: ASA
URL: https://ClinicalTrials.gov/show/NCT02064439
Study 221:
Title: Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Recruitment: Available
Study Results: No Results Available
Study Results: Chronic Myeloid Leukemia
Interventions: Drug: bosutinib
URL: https://ClinicalTrials.gov/show/NCT01903733
Study 252:
Title: To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) ß-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care
Recruitment: Not yet recruiting
Study Results: No Results Available
Study Results: Beta-Thalassemia
Interventions: Other: Quality of Life (QOL) questionnaires|Other: Healthcare Resource Utilization
URL: https://ClinicalTrials.gov/show/NCT0262668
Study 304:
Title: Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Congenital Bleeding Disorder|Haemophilia A
Interventions: Drug: Concizumab|Drug: placebo
URL: https://ClinicalTrials.gov/show/NCT02490787
Study 313:
Title: Adherence to New Oral Anticoagulation Therapy in Turkey
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Atrial Fibrillation
Interventions:
URL: https://ClinicalTrials.gov/show/NCT02480920
Study 383:
Title: Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Von Willebrand Disease
Interventions: Biological: Recombinant von Willebrand Factor (rVWF)
URL: https://ClinicalTrials.gov/show/NCT02283268
Study 390:
Title: Gram-negative Bacteremia in HSCT Recipients
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Allogeneic or Autologous HSCT
Interventions:
URL: https://ClinicalTrials.gov/show/NCT02257931
Study 393:
Title: Thrombolytic Therapy Versus Surgery for Obstructive Prosthetic Valve Thrombosis
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Obstructive Thrombus
Interventions: Drug: Thrombolytic Therapy|Procedure: Surgery
URL: https://ClinicalTrials.gov/show/NCT02243839
Study 410:
Title: A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients With Multiple Myeloma Following Autologous Stem Cell Transplant
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Multiple Myeloma|Autologous Stem Cell Transplant
Interventions: Drug: Ixazomib Citrate|Drug: Placebo
URL: https://ClinicalTrials.gov/show/NCT02181413
Study 445:
Title: Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Venous Thromboembolism
Interventions:
URL: https://ClinicalTrials.gov/show/NCT02017743
Study 493:
Title: A Study to Investigate the Safety and Efficacy of an Anti-IFN? mAb in Children Affected by Primary Haemophagocytic Lymphohistiocytosis
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Primary Hemophagocytic Lymphohistiocytosis
Interventions: Biological: NI-0501
URL: https://ClinicalTrials.gov/show/NCT01818492
Study 494:
Title: Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Hemophilia
Interventions: Other: Recombinant Factor VIII (Kogenate, BAY14-2222)
URL: https://ClinicalTrials.gov/show/NCT01817868
Study 499:
Title: A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069/P06200)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Fungal Infections
Interventions: Drug: Posaconazole|Drug: Voriconazole
URL: https://ClinicalTrials.gov/show/NCT01782131
Study 534:
Title: Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Congenital Bleeding Disorder|Haemophilia A
Interventions: Drug: turoctocog alfa
URL: https://ClinicalTrials.gov/show/NCT01493778
Study 535:
Title: Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Congenital Bleeding Disorder|Haemophilia A
Interventions: Drug: turoctocog alfa pegol
URL: https://ClinicalTrials.gov/show/NCT01489111
Study 544:
Title: Turkish Acquired Haemophilia Registry
Recruitment: Not yet recruiting
Study Results: No Results Available
Study Results: Acquired Haemophilia
Interventions: Drug: rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin
URL: https://ClinicalTrials.gov/show/NCT01403740
Study 556:
Title: Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Myelofibrosis
Interventions: Drug: Ruxolitinib
URL: https://ClinicalTrials.gov/show/NCT01317875
Study 573:
Title: "AIDA" Protocol (LAP 0493)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Leukemia
Interventions: Drug: all-trans retinoic acid (ATRA)
URL: https://ClinicalTrials.gov/show/NCT01064557
Study 579:
Title: VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Atrial Fibrillation|Cardiac Thrombus|Deep Vein Thrombosis|Pulmonary Embolism|Heart Valve Replacement (Mechanical or Biological With AF)|Cardiomyopathy (Ischemic or Dilated)|Peripheral Vascular Disease
Interventions: Drug: Warfarin dose titration
URL: https://ClinicalTrials.gov/show/NCT00970892
Study 581:
Title: Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Myelogenous Leukemia, Chronic
Interventions: Drug: Nilotinib|Drug: Imatinib
URL: https://ClinicalTrials.gov/show/NCT00718263
Study 588:
Title: Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Recruitment: Recruiting
Study Results: No Results Available
Study Results: Primary Immune Deficiency
Interventions:
URL: https://ClinicalTrials.gov/show/NCT00246857


DERNEĞİMİZ

Yönetim Kurulu
Denetim ve Disiplin Kurulları
Bilimsel Alt Komiteler
Üyelik
Tüzük
THD Disiplin Yönergesi
Tarihçe
Faaliyet Kitabı

TOPLANTILAR

Kongre ve Kurslar
HEKHEP ve HALKHEP
Türk Hematoloji Okulu
Eğitim Programı
Diğer Toplantılar

ÖDÜL VE DESTEKLER

Hematoloji Tezi Destek Programı
Araştırma Projelerine Destek Programı
Genç Araştırıcılar İçin Yurt Dışı Desteği
Uluslararası Bilimsel Yayınlara Destek ve
Özendirme Programı

Ulusal Kongre Bildiri Ödülü
HAUD Programı
YDUS Başarı Bursu

HABERLER

Haber ve Duyurular
Basında THD
Endüstriden Haberler
TTB Duyuruları

Anasayfa   |  Dernek Hakkında |  İletişim
2016 © Bu sitenin tüm hakları Türk Hematoloji Derneği'ne aittir.
Kullanım Koşulları

LookUs & Online Makale